IBC Pharma to get two additional patents for Dock-and-Lock Technology Pharmaceutical Business Review IBC Pharmaceuticals, a majority-owned subsidiary of Immunomedics, has received a notice from the US Patent and Trademark Office that it will receive additional two US patents for Dock-and-Lock Technology. The patent application 'Modular Method to ... |
boxing news what time is it current time daylight savings time 2011 spring forward
Aucun commentaire:
Enregistrer un commentaire